...
首页> 外文期刊>Journal of Gastrointestinal Oncology >Clinical characteristics and predictors of 5-year survival among colorectal cancer patients in a tertiary hospital in Malaysia
【24h】

Clinical characteristics and predictors of 5-year survival among colorectal cancer patients in a tertiary hospital in Malaysia

机译:马来西亚三级医院结直肠癌患者5年生存的临床特征及预测因子

获取原文

摘要

Background: Colorectal cancer is the second most common cancer in Malaysia. Its disease burden is likely to increase over time owing to its current trends in this region. This study was undertaken to determine the 5-year survival rate and prognostic factors for survival in colorectal cancer patients treated in a tertiary hospital, in Malaysia. Methods: We reviewed the records of colorectal cancer patients treated in Hospital Tuanku Ja’afar Seremban, Malaysia from 2008 to 2012. Survival analysis at five years was performed using the Kaplan-Meier method. Cox proportional hazard regression analysis was carried out to determine the predictors of 5-year colorectal cancer survival. Results: Of the 275 patients, 43.3% were colon cancers, 51.8% were rectal cancers. Only 2.2% were diagnosed in Stage I. 28.7%, 33.1%, and 16.7% were in Stage II, III and IV respectively; 62/79 (78%) of Stage II patients were in Stage IIb; 15.7% of patients were below the age of 50 and fewer of them presented early (P=0.002). The overall 5-year survival was 46.5%. It was 67.9%, 50.5% and 12.8% for Stage I&II, III and IV patients respectively. Early stage of cancer (P0.001) and age below the mean (P=0.01) were the most significant factor in predicting better survival. Gender and ethnic group were not associated with late presentation nor survival. Neither was there a difference between colon and rectum cancers nor patients who received elective surgical treatment compared to patients receiving other treatment first (P=0.085). Conclusions: Late presentation is the most important predictor for poor outcome for colorectal cancer in Seremban. Patients under the age of 50 years present late more often, but do not have poorer survival.
机译:背景:结直肠癌是马来西亚的第二次常见的癌症。由于其目前该地区的趋势,其疾病负担可能会随着时间的推移而增加。本研究旨在确定在马来西亚在第三级医院治疗的结肠直肠癌患者中生存率的5年生存率和预后因素。方法:从2008年至2012年审查了在马来西亚州豪富·贾阿克法尔Seremban治疗的结肠直肠癌患者的记录。使用Kaplan-Meier方法进行五年的生存分析。 COX比例危害回归分析确定5年结直肠癌存活的预测因子。结果:275例患者,43.3%是结肠癌,51.8%是直肠癌。仅2.2%诊断为I.28.7%,33.1%和16.7%分别在第II阶段,III和IV中; 62/79(78%)阶段II阶段患者在阶段IIB; 15.7%的患者低于50岁,较少的患者早期呈现(p = 0.002)。整体5年生存率为46.5%。阶段I&II,III和IV患者分别为67.9%,50.5%和12.8%。癌症的早期阶段(P <0.001)和低于平均值(p = 0.01)是预测更好存活的最重要因素。性别和民族与晚期介绍和生存无关。结肠和直肠癌之间也没有差异,与首先接受其他治疗的患者相比,接受选修外科治疗的患者(P = 0.085)。结论:晚期呈现是Seremban中结肠直肠癌差异最重要的预测因子。 50岁以下的患者往往往往更常见,但没有较差的生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号